Кальций-связывающие белки при ревматических заболеваниях

1. <div><p>Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003;423:356-61.</p><p>Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003;73:209-12.</p><p>Oppenheim J.J., Yang D. Alarmins: chemotactic activators of immune responses. Curr Opin Immunol 2005;17:359-65</p><p>Roth J., Vogl T., Sorg C., Sunderkotter C. Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules. Trends Immunol 2003;24:155-8.</p><p>Moore B.W. A soluble protein characteristic of the nervoussystem. Biochem Biophys Res Commun 1965;19:739-44.</p><p>Heizmann C.W., Fritz G., Schafer B.W. S100 proteins: structure, functions and pathology. Front Biosci 2002;7;1356-68.</p><p>Marenholz I., Heizmann C.W., Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun 2004;322:1111-22.</p><p>Lagasse E., Clerc R.G. Cloning and expression of two human genes encoding calcium-binding proteins that are regulated during myeloid differentiation. Mol Cell Biol 1988;8:2402-10.</p><p>Odink K., Cerletti N., Bruggen J. et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 1987;330:80-2.</p><p>Zwadlo G., Bruggen J., Gerhards G. et al. Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues. Clin Exp Immunol 1988;72:510-5.</p><p>Dorin J.R., Novak M., Hill R.E. et al. A clue to the basic defect in cystic fibrosis fromcloning the CF antigen gene. Nature 1987;326:614-7.</p><p>Roth J., Teigelkamp S., Wilke M. et al. Complex pattern of the myelo-monocytic differentiation antigens MRP8 and MRP14 during chronic airway inflammation. Immunobiology 1992;186:304-14.</p><p>Frosch M., Metze D., Foell D. et al. Early activation of cutaneous vessels and epithelial cells is characteristic of acute systemic onset juvenile idiopathic arthritis. Exp Dermatol 2005;14:259-65.</p><p>Zenz R., Eferl R., Kenner L. et al. Psoriasis like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 2005;437:369-75.</p><p>Vogl T., Propper C., Hartmann M. et al. S100A12 is expressed exclusively by granulocytes and acts independently from MRP8 and MRP14. J Biol Chem 1999;274:25291-6.</p><p>Roth J., Burwinkel F., van den Bos C. et al. MRP8 and MRP14, S-100-like proteins associated with myeloid differentiation, are translocated to plasma membrane and intermediate filaments in a calcium-dependent manner. Blood 1993;82:1875-83.</p><p>Dale I., Fagerhol M.K., Naesgaard I. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. Eur J Biochem 1983;15(134):1-6.</p><p>Steinbakk M., Naess-Andresen C.F., Lingaas E. et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin. Lancet 1990;336:763-5.</p><p>Roseth A.G., Fagerhol M.K., Aadland E., Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.</p><p>Fagerhol M.K., Nielsen H.G., Vetlesen A. et al. Increase in plasma calprotectin during long distance running. Scand J Clin Lab Invest 2005;65:211-20.</p><p>Berntzen H.B., Munthe E., Fagerhol M.K. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989;16:1416-20.</p><p>Berntzen H.B., Fagerhol M.K., Ostensen M. et al. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. J Rheumatol 1991;18:133-8.</p><p>Brun J.G., Haga H.J., Boe E. et al. Calprotectin in patients with rheumatoid arthritis: relation to clinical and laboratory variables of disease activity. J Rheumatol 1992;19:859-62.</p><p>Brun J.G., Jonsson R., Haga H.J. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733-7.</p><p>Frosch M., Vogl T., Seeliger S. et al. Expression of myeloid related proteins 8 and 14 in systemic-onset juvenile rheumatoid arthritis. Arthr Rheum 2003;48:2622-6.</p><p>Haga H.J., Brun J.G., Berntzen H.B. et al. Calprotectin in patients with systemic lupus erythematosus: relation to clinical and laboratory parameters of disease activity. Lupus 1993;2:47-50.</p><p>Hammer H.B., Odegard S., Syversen S.W. et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis 2010;69:150-4.</p><p>Hammer H.B., Odegard S., Fagerhol M.K. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis 2007;66:1093-7.</p><p>Youssef P., Roth, J., Frosch M. et al. Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane. J Rheumatol 1999;26:2523-8.</p><p>Berntzen H.B., Olmez U., Fagerhol M.K., Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991;20:74-82.</p><p>Kane D., Roth J., Frosch M. et al. Increased perivascular synovial membrane expression of myeloidrelated proteins in psoriatic arthritis. Arthr Rheum 2003;48:1676-85.</p><p>Frosch M., Strey A., Vogl T. et al. Myeloid related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthr Rheum 2000;43:628-37.</p><p>Baillet A. S100A8, S100A9 and S100A12 proteins in rheumatoid arthritis. Rev Med Interne 2010;31:458-61.</p><p>Brun J.G., Jonsson R., Haga H.J. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994;21:733-8.</p><p>Berntzen H.B., Munthe E., Fagerhol M.K. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. J Rheumatol 1989;16:1416-20.</p><p>Frosch M., Vogl T., Seeliger S. et al. Expression of myeloid-related proteins 8 and 14 in systemic onset juvenile rheumatoid arthritis. Arthr Rheum 2003;48:2622-6.</p><p>Foell D., Frosch M., Schulze zur Wiesch A. et al. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? Ann Rheum Dis 2004;63:206-8.</p><p>Schulze zur Wiesch A., Foell D., Frosch M. et al. Myeloid related proteins MRP8/MRP14 may predict disease flares in juvenile idiopathic arthritis. Clin Exp Rheumatol 2004;22:368-73.</p><p>Wulffraat N.M., Haas P.J., Frosch M. et al. Myeloid related protein 8 and 14 secretion reflects phagocyte activation and correlates with disease activity in juvenile idiopathic arthritis treated with autologous stem cell transplantation. Ann Rheum Dis 2003;62:236-41.</p><p>Frosch M., Ahlmann M., Vogl T. et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. Arthr Rheum 2009;60:883-91.</p><p>Seeliger S., Vogl T., Engels I.H. et al. Expression of calcium-binding proteins MRP8 and MRP14 in inflammatory muscle diseases. Am J Pathol 2003;163:947-56.</p><p>Rastaldi M.P., Ferrario F., Crippa A. et al. Glomerular monocytemacrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J Am Soc Nephrol 2000;11(11):2036-43.</p><p>Rugtveit J., Nilsen E., Bakka A. et al. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology1997;112:1493-505.</p><p>Uchida T., Fukawa A., Uchida M. et al. Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. J Proteome Res 2002;1:495-9.</p><p>Jung S.Y., Park Y.B., Ha Y.J. et al. Serum calprotectin as a marker for disease activity and severity in adult-onset Still's disease. Науч-практич ревматол 2012; 50(1): 60-64 63 J Rheumatol 2010;37:1029-34.</p><p>Roseth A.G., Schmidt P.N., Fagerhol M.K. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol 1999;34:50-4.</p><p>Lugering N., Stoll R., Kucharzik T. et al. Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion 1995;56:406-14.</p><p>Tacheci I., Kopacova M., Rejchrt S., Bures J. Non-steroidal anti-inflammatory drug induced injury to the small intestine. Acta Medica (Hradec Kralove) 2010;53:3-11.</p><p>Каратеев А.Е., Насонов Е.Л. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. РМЖ 2006;25:1769-77.</p><p>Чичасова Н.В. Эффективность нестероидных противовоспалительных препаратов в клинической практике. РМЖ 2006;25:179</p><p>Bogas M., Afonso Mdo C., Araujo D. Non-steroidal anti-inflammatory drugs and lower intestinal tract toxicity. Acta Reumatol Port 2006;31:227-35.</p><p>Муравьев Ю.В., Лебедева В.В. Нерешенные вопросы энтеропатии, индуцированной нестероидными противовоспалительными препаратами. Тер арх 2009;2:90-3.</p><p>Page T.H., Turner J.J., Brown A.C. et al. Nonsteroidal anti-inflammatory drugs increase TNF production in rheumatoid synovial membrane cultures and whole blood. J Immunol 2010;185:3694-701.</p><p>Tugendreich S., Pearson C.I., Sagartz J. et al. Nsaid-induced acute phase response is due to increased intestinal permeability and characterized by early and consistent alterations in hepatic gene expression. Toxicol Pathol 2006;34:168-79.</p><p>Пасечников В.Д., Бобрышев Д.В., Витковский Ю.В. Нестероидные гастропатии: опыт использования арторотека. Medical Marcet 1997;25:46-7.</p><p>Nalbant S., Akmaz I., Kaplan M. et al. Does rofecoxib increase TNF-alpha levels? Clin Exper Rheumatol 2006;24:361-5.</p><p>Lanas A., Scarpignato C. Microbial flora in NSAID-induced intestinal damage: a role for antibiotics? Digestion 2006;73(Suppl. 1):136-50.</p><p>Thornjopleifsson B., Theodors A., Bjarnason I. The effect of diclofenac on the small intestine studied by wireless endoscopy. Laeknabladid 2004;90:689-93.</p><p>Meling T.R., Aabakken L., Roseth A. et al. Faecal calprotectin shedding after short-term treatment with non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1996;31:339-44.</p><p>Tibble J.A., Sigthorsson G., Foster R. et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. Gut 1999;45:362-6.</p><p>Montalto M., Curigliano V., Santoro L. et al. Prophylactic aspirin therapy does not increase faecal calprotectin concentrations. Eur J Gastroenterol Hepatol 2006;18:965-7.</p><p>Montalto M., Gallo A., Ianiro G. Can chronic gastritis cause an increase in fecal calprotectin concentrations? World J Gastroenterol 2010;16:3406-10.</p><p>Fortun P.J., Hawkey C.J. Nonsteroidal anti-inflammatory drugs and the small intestine. Curr Opin Gastroenterol 2005;21:169-75.</p><p>Fortun P.J., Hawkey C.J. Nonsteroidal antiinflammatory drugs and the small intestine. Curr Opin Gastroenterol 2007;23:134-41.</p><p>Sightorsson G., Tibble J., Hayllar J. et al. Intestinal permeability and inflammation in patients on NSAIDs. Gut 1998;43:506-11.</p><p>Carlsten H., Hilme E., Hedberg M. et al. Elevated levels of faecal calprotectin in two thirds of patients with ankylosing spondilitis. Ann Rheum Dis 2010;69(Suppl. 3):696.</p><p>Roseth A.G., Fagerhol M.K., Aadland E., Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992;27:793-8.</p><p>Shitrit A.B., Braverman D., Stankiewics H. et al. Fecal calprotectin as a predictor of abnormal colonic histology. Dis Colon Rectum 2007;50:2188-93.</p><p>Ilg E.C., Troxler H., Burgisser D.M. et al. Amino acid sequence determination of human S100A12 (P6, calgranulin C, CGRP, CAAF1) by tandem mass spectrometry. Biochem Biophys Res Commun 1996;225:146-50.</p><p>Wicki R., Marenholz I., Mischke D. et al. Characterization of the human S100A12 (calgranulin C, p6,CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21. Cell Calcium 1996;20:459-64.</p><p>Madland T.M., Hordvik M., Haga H. et al. Leukocyte protein calprotectin and outcome in rheumatoid arthritis. A longitudinal study. Scand J Rheumatol 2002;31:351-4.</p><p>Frosch M., Strey A., Vogl T. et al. Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium an dare useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthr Rheum 2000;43:628-37.</p><p>Tibble J.A., Bjarnason I. Non-invasive investigation of inflammatory bowel disease. World J Gastroenterol 2001;7:460-5.</p><p>Abe J., Jibiki T., Noma S. et al. Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 2005;174;5837-45.</p><p>McCormick M.M., Rahimi F., Bobryshev Y.V. et al. S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 2005;280:41521-9.</p><p>Frosch M., Vogl T., Waldherr R. et al. Expression of MRP8 and MRP14 by macrophages is a marker forsevere forms of glomerulonephritis. J Leukoc Biol 2004;75:198-206.</p><p>Kuruto R., Nozawa R., Takeishi K. et al. Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases. J Biochem 1990;108:650-3.</p><p>Hofmann M.A., Drury S., Hudson B.I. et al. RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response. Genes Immun 2002;3:123-35.</p><p>Rouleau P., Vandal K., Ryckman C. et al. The calcium-binding protein S100A12 induces neutrophil adhesion, migration, and release from bone marrow in mouse at concentrations similar to those found in human inflammatory arthritis. Clin Immunol 2003;107:46-54.</p><p>Foell D., Kane D., Bresnihan B. et al. Expression of the proinflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 2003;42:1383-9.</p><p>Yang Z., Tao T., Raftery M.J. et al. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol 2001;69:986-94.</p><p>Foell D., Wittkowski H., Hammerschmidt I. et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Arthr Rheum 2004;50:1286-95.</p><p>Foell D., Hernandez-Rodriguez J., Sanchez M. et al. Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis. J Pathol 2004;204(3):311-6.</p><p>Ye F., Foell D., Hirono K.I. et al. Neutrophil-derived S100A12 is profoundly upregulated in the early stage of acute Kawasaki disease. Am J Cardiol 2004;94:840-4.</p><p>Foell D., Ichida F., Vogl T. et al. S100A12 (EN-RAGE) in monitoring Kawasaki disease. Lancet 2003;361:1270-2.</p><p>Foell D., Kucharzik T., Kraft M. et al. Neutrophil-derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease. Gut 2003;52:847-53.</p><p>Kosaki A., Hasegawa T., Kimura T. et al. Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 2004;89:5423-8.</p><p>Liao H., Wu J., Kuhn E. et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthr Rheum 2004;50:3792-803.</p><p>Hammer H.B., Kvien T.K., Glennas A., Melby K. A longitudinal study of calprotectin as an inflammatory marker in patients with reactive arthritis. Clin Exp Rheumatol 1995;13:59-64.</p><p>Brun J.G., Madland T.M., Gran J.T., Myklebust G. A longitudinal study of calprotectin in patients with polymyalgia rheumatica or temporal arteritis: relation to disease activity. Scand J Rheumatol 2005;34:125-8.</p></div><br />